RE: Amgen4 Jun 2025 10:02
LOL
more likely, they will get in 0.15-0.20 in the discounted placing which cant be more than a few weeks away now. Having just kicked CLX down the road by another 12 mths which was to be expected, i previously commented that one was two or three more raises or more away from any possible chance of a commercial deal, as @Grainger14 put it, they "have nothing" here. This is the legacy ME inherited, evaluations neglected whilst Suzy played labs and to rebuild a pipeline now will take years and more raises, that's time lost and money you cant get back.
If you are holding out for cash to drop for 201, Jesus its older than hens teeth now, the tech superseded years ago, zero chance IMO and as for 401, really? Ambrose don't have the cash to pay VAL big upfront cash amounts and moreover in this climate faced with costs to develop 401, that's if its even worth the investment as its practically as old as 201 now, it would be utter madness to chuck cash on upfront fees.
Sorry but cash in can only come from investors, that's the reality now and the clock is ticking again,,,, my call is a discounted raise of 0.15 to get it away then a 125:1 consolidation event after. Place your bets.